Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
ENT in Cayman Performs First Cochlear Implant in the Cayman Islands at Health City
EIN Presswire
GRAND CAYMAN, CAYMAN ISLANDS, April 10, 2026 /EINPresswire.com/ -- ENT in Cayman Ltd., in collaboration with Health City Cayman Islands, has performed and activated the first cochlear implant in the Cayman Islands, marking a major advancement in...
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED ANNUAL REPORT
GlobeNewswire, Inc.
New York, NY, April 21, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on April 17, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq...
Health City Cayman Islands Performs First Robotic Cardiac Surgery
EIN Presswire
GRAND CAYMAN, CAYMAN ISLANDS, January 20, 2026 /EINPresswire.com/ -- Health City Cayman Islands has successfully completed its first robotic-assisted cardiac surgeries, marking a major breakthrough for advanced heart care in the Cayman Islands...
EC Assets Delivers Easter Joy to Patients at Monaco's Princess Grace Hospital
EIN Presswire
The alternative investment firm donated Easter gift bags filled with sweets and small surprises to patients spending the holiday at CHPG Monaco.
Silexion Therapeutics to Participate in September 2026 Industry and Investor Conferences
GlobeNewswire, Inc.
Grand Cayman, Cayman Islands, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers,...
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
GlobeNewswire, Inc.
Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting highly prevalent KRAS-driven cancers with...
Silexion Therapeutics Receives Approval from Israeli Ministry of Health to Initiate Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer
GlobeNewswire, Inc.
Significant regulatory milestone marks advancement into clinical-stage development of next-generation RNAi therapy featuring an innovative, integrated systemic treatment delivery approach targeting highly prevalent KRAS-driven cancers with...
Health City Cayman Islands’ Shomari Scott Receives 2025 CMEx Leadership Award in Miami
EIN Presswire
MIAMI, FL, UNITED STATES, December 11, 2025 /EINPresswire.com/ -- Shomari Scott, Chief Business Officer of Health City Cayman Islands and a seasoned tourism and brand strategist, was honored with a 2025 Caribbean Media Exchange (CMEx) Leadership...
Project Kontrast Founder Kameron Katsch Unveils THE WHOLE THING, a Unified Humanitarian Platform Targeting Global Energy, Health, and Workforce Challenges by 2030
GlobeNewswire, Inc.
CAYMAN ISLANDS, March 11, 2026 (GLOBE NEWSWIRE) -- Kameron Katsch, founder and CEO of Project Kontrast, today announced the official launch of THE WHOLE THING, a large-scale humanitarian framework designed to address some of the most critical...
Health City Cayman Islands Sleep Lab Marks 2,000th Patient, a Major Milestone for Regional Sleep Medicine
EIN Presswire
GRAND CAYMAN, CAYMAN ISLANDS, November 19, 2025 /EINPresswire.com/ -- Health City Cayman Islands has reached a significant milestone, with its Sleep Lab having treated its 2,000th patient since opening in 2015. The achievement underscores the...
CORXEL to Participate in Upcoming Investor Conferences
GlobeNewswire, Inc.
BERKELEY HEIGHTS, N.J., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Corxel Pharmaceuticals Limited (“CORXEL” or the “Company”), a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic...
Fitell Corporation Announces Completion of Redomiciliation to the British Virgin Islands
GlobeNewswire, Inc.
Taren Point, Australia, March 05, 2026 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”) announced completion of its redomiciliation from the Cayman Islands to the British Virgin Islands as a BVI business company...
Cayman Islands Director of Tourism Shares Why the Cayman Islands Is the Antidote to Stressful Vacations on YourUpdateTV
GlobeNewswire, Inc.
NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) -- As families brace for holiday travel chaos, the Cayman Islands is offering a welcome antidote: a vaCay that restores instead of exhausts.
Health City Cayman Islands Welcomes Its Parent Company’s Acquisition of Practice Plus Group
EIN Presswire
CAYMAN ISLANDS, November 1, 2025 /EINPresswire.com/ -- Health City Cayman Islands, the largest private sector medical entity in the Cayman Islands and one of the largest in the Caribbean, has announced the acquisition of Practice Plus Group by...
Young Caymanian Overcomes Cervical Cancer at 27
EIN Presswire
Shares Story of Faith and Resilience on World Cancer Day GRAND CAYMAN, CAYMAN ISLANDS, February 5, 2026 /EINPresswire.com/ -- A 27-year-old Cayman resident is now cancer-free after battling stage 2B cervical cancer and is sharing her story of...
Health City Cayman Islands Rebrands Flagship Youth Program as Health City Explorers
EIN Presswire
CAYMAN ISLANDS, September 28, 2025 /EINPresswire.com/ -- Health City Cayman Islands has rebranded its flagship youth program, Healthcare Explorers, as Health City Explorers to strengthen the program’s connection to the internationally recognized...
JOE BONAMASSA & SIXTHMAN ANNOUNCE KEEPING THE BLUES ALIVE AT SEA XII SAILING MARCH 15-19, 2027 - MIAMI TO GRAND CAYMAN
EIN Presswire
THIS 12TH YEAR EVENT INCLUDES AN EXCLUSIVE EXPERIENCE HENDRIX SET WITH JOE BONAMASSA & KENNY WAYNE SHEPHERD AND AN ALL-STAR LINEUP – JOIN THE PRESALE NOW MIAMI , FL, UNITED STATES, February 3, 2026 /EINPresswire.com/ -- 5x GRAMMY®...
Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer
GlobeNewswire, Inc.
Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies, positive German regulatory feedback, and strong...
Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer
GlobeNewswire, Inc.
Positive feedback reinforces Silexion’s trajectory toward its planned Phase 2/3 trial initiation in Q2 2026 Company plans to complete regulatory submissions to the Israeli Ministry of Health by the end of Q4 2025 and in Germany during Q1 2026...
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
GlobeNewswire, Inc.
Successful completion of two-species toxicology studies confirms no systemic organ toxicity, advancing the Company towards its planned regulatory submissions to Israel and Germany Company remains on track to initiate Phase 2/3 clinical trial in...
Sign up for:
Wellness Focus Cayman Islands
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.